Clinical Trials Logo

Filter by:
NCT ID: NCT05371340 Completed - Clinical trials for Osteoporosis, Postmenopausal

Quercetin's Effect on Bone Health and Inflammatory Markers

Start date: August 27, 2019
Phase: N/A
Study type: Interventional

Quercetin is a plant-based flavonoid that is naturally found in many fruits and vegetables, and is considered to be a potent antioxidant with several expected health benefits such as anti-inflammatory effects and bone-conserving properties. Participants will supplement with either Quercetin, or placebo, for 90-days with pre- and post-testing visits.

NCT ID: NCT05370859 Completed - Cancer Clinical Trials

mMe: Motivational Monitoring to Enhance Smoking Cessation Among Cancer Patients

mMe
Start date: July 18, 2022
Phase:
Study type: Observational

The objectives of this study are to pilot test a protocol of weekly assessments of motivation to quit and other relevant constructs combined with information about how to enroll in cessation programs, which will allow initial quantification of motivation to quit during cancer treatment and develop hypotheses about the impact of motivation on the decision to enroll in services.

NCT ID: NCT05370638 Completed - Hospitalism Clinical Trials

Discharge in the AM

Start date: February 9, 2021
Phase: N/A
Study type: Interventional

As hospitals around the country continue to work to manage a high patient census, provider prioritization of discharges is one low cost mechanism to help improve patient throughput and patient length of stay. The investigators conducted a prospective randomized study to understand if this commonly utilized approach to expedite care results in earlier discharges and lower hospital lengths of stay while also understanding the impact on other patient care (such as test and consult order times on other patients that the physician is caring for).

NCT ID: NCT05370521 Completed - Clinical trials for Polycystic Ovary Syndrome

A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens

Start date: May 15, 2022
Phase: Phase 2
Study type: Interventional

An investigation of the safety and efficacy of tildacerfont in women with PCOS and elevated adrenal androgens

NCT ID: NCT05370495 Completed - Dry Eye Disease Clinical Trials

Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease

Start date: July 25, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This is a phase 2, multi-center, double-masked, randomized, vehicle-controlled, dose-response, parallel-group study designed to evaluate the safety and tolerability and ocular efficacy of SY-201 Ophthalmic Solution versus vehicle over a 60-day treatment period in subjects with dry eye disease (DED).

NCT ID: NCT05370339 Completed - Type 1 Diabetes Clinical Trials

Assessment of Sleep and Sleep Disruptors in Adolescents With Type 1 Diabetes

Start date: June 15, 2022
Phase:
Study type: Observational

The goal of this study is to identify causes of insufficient sleep and sleep disruptors in adolescents with type 1 diabetes. For this study, adolescents will wear an actigraphy watch and complete sleep diaries for seven days. On completion of the seven days, they will complete several questionnaires regarding sleep, fear of hypoglycemia, and anxiety and depression. A subset of participants will additionally complete a qualitative interview session to obtain a deeper understanding of sleep disruptors and barriers and facilitators to improving sleep health.

NCT ID: NCT05370326 Completed - Chronic Pain Clinical Trials

Feasibility and Preliminary Efficacy of an Opioid Stewardship Program in Hospitalized Patients With Chronic Pain

Start date: July 7, 2022
Phase: N/A
Study type: Interventional

This study aims to investigate the feasibility and preliminary efficacy of an enhanced opioid stewardship program, tailored to the needs of hospitalized patients with chronic pain with opioid dependence, incorporating real-time guidance from an addiction medicine and pain-trained physician/pharmacist team, using a pilot randomized clinical trial format. Findings from this research may improve pain management and decrease risk of opioid-related adverse events among patients with chronic pain.

NCT ID: NCT05370196 Completed - Clinical trials for Sexually Transmitted Diseases

Synthetic Male Condom Slippage-Breakage Study

Start date: June 10, 2022
Phase: N/A
Study type: Interventional

This is a multi-site, double-blind, crossover, randomized phase II study to evaluate the functional performance of a synthetic male condom as compared to a marketed latex condom.

NCT ID: NCT05370157 Completed - Implementation Clinical Trials

TeamTRACS Pilot (CTSI)

Start date: June 8, 2022
Phase: N/A
Study type: Interventional

In a previous research study, the investigators adapted an evidence-based team training intervention for healthcare settings (TeamSTEPPS) to fit the needs and context of Child Advocacy Center multidisciplinary teams. This study is a cluster-randomized controlled trial of the adapted training, TeamTRACS (Team Training in Roles, Awareness, Communication, and Support). This hybrid type 2 effectiveness-implementation study will test the effectiveness of TeamTRACS and pilot a self-guided approach to implementing TeamTRACS in low-resource settings.

NCT ID: NCT05369533 Completed - Stroke Clinical Trials

Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke

Start date: August 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This study explores the effects of telerehabilitation and a study medication on rehabilitation outcomes in patients with stroke resulting in arm weakness. Patients with arm weakness due to a stroke that happened in the past 30 days will be randomized into one of three groups: [1] TR and placebo (a sugar pill) on top of usual care; [2] TR and a medication (Sinemet 25/100) on top of usual care; [3] or usual care alone (no TR and no pill, but people in this group will be offered TR once the study is done). TR consists of 70 minutes/day of activities targeting arm function, 6 days a week for 6 weeks.